Source comparison
TP-7 Same as Selank Amidate: Comparison Across Research Protocols
Selank Russia, Eastern Europe Anxiolytic mechanisms, GABA-A modulation, immune function studies Listed under proprietary pharmaceutical name; often includes clinical trial citations Russian Pharmacopoeia standards; HPLC purity ≥98% Original pharmaceutical desi
This comparison does not assign a generated winner or score.
- Selank
- Russia, Eastern Europe
- Anxiolytic mechanisms, GABA-A modulation, immune function studies
- Listed under proprietary pharmaceutical name; often includes clinical trial citations
- Russian Pharmacopoeia standards; HPLC purity ≥98%
- Original pharmaceutical designation—most cited in Russian-language literature but less common in Western supplier catalogues
- TP-7
- Western Europe, North America
- Nootropic pathways, neurotransmitter kinetics, receptor binding assays
- Indexed as 'TP-7 (tuftsin peptide-7)' with sequence listed explicitly
- USP or EP monograph compliance; third-party COA with mass spectrometry
- Most transparent naming for structural verification—sequence is explicit rather than proprietary
- Selank Amidate
- United States, Canada
- Cognitive enhancement research, stress response studies, neuroplasticity protocols
- Listed as 'Selank Amidate' with acetylation specified; often includes CAS number
- FDA-registered 503B facility standards when available; lyophilised powder with bacteriostatic water separate
- Clarifies acetylated form explicitly—useful when verifying that the product matches published protocols requiring N-terminal modification